As shown in Table 2, tumor size, lymph node metastasis, histological grade, node stage, TNM stage, and DSCR1 expression was responsible for the OS of CRC patients in the test cohort. The gene discussed is RCAN1; the disease is metastatic malignant neoplasm in the lymph nodes.